Lupin Ltd

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40002438

Informations générales

Localisation

India

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

04/12/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2033

Statut

Targets set

Classification

1.5°C

Année cible

FY2033

Progression vers l'objectif0%
2015 (année de référence)FY2033
Description complète des objectifs

Near-Term Targets: Lupin Ltd commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by FY2030 from a FY2023 base year.* Lupin Ltd also commits to reduce scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, business travel, employee commuting, downstream transportation and distribution, processing of sold products, use of sold products and franchises 61.07% per INR value added by FY2033 from a FY2024 base year. *The target boundary includes land-related emissions and removals from biogenic feedstocks.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

INE326A01037

LEI

335800HHXTESDEE2FC65

Source : Science Based Targets initiative | Données publiques